Columbia University Medical, Herbert Irving Comprehensive Cancer Center — New York, New York

Columbia University Medical, Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Medical, Herbert Irving Comprehensive Cancer Center has participated in 1 clinical trials.

Therapeutic areas: AML.

Sponsors: Actinium Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Medical, Herbert Irving Comprehensive Cancer Center?

Columbia University Medical, Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Medical, Herbert Irving Comprehensive Cancer Center conducted?

Columbia University Medical, Herbert Irving Comprehensive Cancer Center has 1 clinical trials on record. Their work covers AML.

Is Columbia University Medical, Herbert Irving Comprehensive Cancer Center accredited by Crixeo Health?

Columbia University Medical, Herbert Irving Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Medical, Herbert Irving Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.